When contemplating new biopharmaceutical development and manufacturing facility construction, there are three commonly pursued industry options, Conventional, Modular, and Podular. Prior to embarking on a capital-intensive building project, it should be considered whether one of these three is a preferred approach. There is credible evidence to suggest that offsite prefabrication of a facility shell/utilities core and its modular equipment platform…